Alexander Simon, Assil-Ramin Alimy, Johannes Krug, Björn Busse, Frank Timo Beil, Michael Amling, Felix N von Brackel, Tim Rolvien
{"title":"Depth-specific characterization of bone microarchitecture in the femoral head: implications for osteoarthritis and osteoporosis research.","authors":"Alexander Simon, Assil-Ramin Alimy, Johannes Krug, Björn Busse, Frank Timo Beil, Michael Amling, Felix N von Brackel, Tim Rolvien","doi":"10.1186/s13075-026-03943-2","DOIUrl":"10.1186/s13075-026-03943-2","url":null,"abstract":"<p><strong>Background: </strong>Osteoarthritis (OA) and osteoporosis (OP) are highly prevalent musculoskeletal diseases characterized by cartilage loss and increased subchondral bone formation and by systemic bone mass reduction, respectively. The femoral head is commonly examined in both OA and OP research, yet both conditions may coexist in the same patient, making it unclear how local cartilage degeneration and systemic bone mineral density (BMD), as a marker of OP-related skeletal status, contribute to bone microarchitectural changes at different depths.</p><p><strong>Methods: </strong>Femoral heads were obtained from 30 patients undergoing primary total hip arthroplasty for hip OA. Ex vivo high-resolution peripheral quantitative computed tomography (HR-pQCT) was performed on the entire femoral head, followed by computational segmentation of the subchondral mineralized plate (SMP) and five concentric trabecular regions. Depth-specific bone microarchitectural parameters were analyzed in relation to histologically assessed cartilage degeneration and systemic BMD measured by dual-energy X-ray absorptiometry (DXA).</p><p><strong>Results: </strong>The cohort had a mean age of 75.4 ± 9.5 years, 53.3% were female, and patients spanned the spectrum of normal BMD (36.7%), osteopenia (46.7%), and osteoporosis (16.7%). Trabecular volumetric tissue mineral density (Tb.vTMD), bone volume to tissue volume (BV/TV), and trabecular thickness (Tb.Th) showed an initial decrease in the superficial trabecular regions, followed by a progressive increase toward deeper regions, whereas cyst-like void volume continuously decreased with depth and almost completely disappeared beyond 9.84 mm in depth. Cartilage degeneration independently predicted subchondral bone microstructure within the SMP and in superficial to intermediate trabecular regions (up to 13.12 mm in depth). Specifically, higher OARSI grades were associated with higher SMP.Th, Tb.vTMD, BV/TV, and Tb.Th. Systemic BMD T-score emerged as an independent predictor of trabecular bone parameters across all depths and represented the sole determinant of BV/TV and Tb.Th in the deepest trabecular region (beyond 13.12 mm depth), while cartilage degeneration was not associated with trabecular bone parameters in the deepest trabecular region.</p><p><strong>Conclusions: </strong>Our findings showcase spatially distinct contributions of cartilage degeneration and systemic skeletal status to subchondral bone remodeling, identifying depth as a critical determinant in the analysis of osteochondral alterations in hip OA. Specifically, our findings emphasize that systemic BMD should be considered a covariate in OA research and that deep regions of the femoral head should be used for OP research to minimize potential confounding by local OA-related effects.</p>","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"28 1","pages":""},"PeriodicalIF":4.6,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13737963/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nora Euler, Ana Cristina Gonzalez-Sanchez, Elizabeth Clark, Hedvig Mildner, Marina Galesic, Andrea Kemp, Mattias Jangard, Erik Hellbacher, Nils Landegren, Lina Marcela Diaz-Gallo, Lars Klareskog, Vivianne Malmström, Eva Baecklund, Caroline Grönwall
{"title":"Diffuse large B cell lymphoma in rheumatoid arthritis express polyreactive and autoreactive BCRs binding protein modifications.","authors":"Nora Euler, Ana Cristina Gonzalez-Sanchez, Elizabeth Clark, Hedvig Mildner, Marina Galesic, Andrea Kemp, Mattias Jangard, Erik Hellbacher, Nils Landegren, Lina Marcela Diaz-Gallo, Lars Klareskog, Vivianne Malmström, Eva Baecklund, Caroline Grönwall","doi":"10.1186/s13075-026-03937-0","DOIUrl":"https://doi.org/10.1186/s13075-026-03937-0","url":null,"abstract":"<p><strong>Background: </strong>An important risk factor for diffuse large B-cell lymphoma (DLBCL) development in patients with rheumatoid arthritis (RA) is high cumulated disease activity. B cell intrinsic factors and autoimmune processes may contribute, and we hypothesize that BCR autoreactivity may drive lymphomagenesis and/or lymphoma cell survival. RA is primarily associated with anti-citrullinated protein autoantibodies but patients can also have other anti-modified protein autoantibodies, e.g. towards malondialdehyde acetaldehyde (MDA/MAA) adducts which correlate with disease activity and inflammation. Here, we investigated DLBCL properties from RA patients with concurrent lymphoma by B-cell receptor (BCR) next generation sequencing and re-expression.</p><p><strong>Methods: </strong>In total 22 RA-DLBCL patients were included from the Swedish AUTO-LYMPHOMA cohort. Tumour DNA was extracted from fixed tissues and full length VH/VL fragments were amplified by multiplex PCR and sequenced using Illumina. Computational analysis assessed clonal variations. Dominating sequences were synthesized and expressed as recombinant monoclonal antibodies for antigen binding analysis.</p><p><strong>Results: </strong>Complete VH/VL lymphoma tissue sequences were generated from nine RA-DLBCL patients. Clonotype diversity within the tumour was generally low and the dominant paired heavy and light chain BCR sequences were obtained for six patients. For three patients, amino acid variations in the DLBCL clonotype indicated intra-clonal evolution. Two of six patients had tumour BCRs with few VH and VL somatic hypermutations (≤ 5 mismatches) while three had high mutations (> 15 VH or VL mismatches). No bias in VH/VL usage was detected. Six lymphoma BCRs from five patients were expressed as recombinant monoclonal antibodies and their binding to autoantigens was assessed by ELISA and a solid-phase microarray (> 400 antigens). All patient-derived lymphoma BCRs were CCP2 negative, but five bound MDA/MAA-protein. Three of these displayed polyreactive binding by in-house assays of which two further displayed strikingly broad polyreactivity on the antigen array. Importantly, for one patient, the lymphoma BCR had high specificity to MDA/MAA-protein, and another patient DLBCL-BCR had binding only to methylated protein.</p><p><strong>Conclusions: </strong>The data suggest a possible link between polyreactivity and anti-MDA/MAA autoreactivity in RA-DLBCL lymphomagenesis. We hypothesize that high inflammation burden could increase antigen load which may trigger polyreactive and modified-protein B cell responses and/or maintain lymphoma cell survival.</p>","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"28 1","pages":""},"PeriodicalIF":4.6,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13711851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149285148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aoife M O'Byrne, Janne W Bolt, Chaja M J van Ansenwoude, Martijn van der Heide, Johanna F Semmelink, Aldo Jongejan, Perry D Moerland, Mario Maas, Marleen G H van de Sande, Lisa G M van Baarsen
{"title":"Correction: Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients.","authors":"Aoife M O'Byrne, Janne W Bolt, Chaja M J van Ansenwoude, Martijn van der Heide, Johanna F Semmelink, Aldo Jongejan, Perry D Moerland, Mario Maas, Marleen G H van de Sande, Lisa G M van Baarsen","doi":"10.1186/s13075-026-03936-1","DOIUrl":"https://doi.org/10.1186/s13075-026-03936-1","url":null,"abstract":"","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"28 1","pages":""},"PeriodicalIF":4.6,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13711977/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149284970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vanessa Bartsch, Basel Habboub, Johannes Knitza, Mathias Ausserwinkler, Stefan Knop, Georg Schett, Axel J Hueber
{"title":"Comorbidity management in inflammatory rheumatic diseases: a dual-perspective survey of patients and rheumatologists.","authors":"Vanessa Bartsch, Basel Habboub, Johannes Knitza, Mathias Ausserwinkler, Stefan Knop, Georg Schett, Axel J Hueber","doi":"10.1186/s13075-026-03924-5","DOIUrl":"https://doi.org/10.1186/s13075-026-03924-5","url":null,"abstract":"<p><strong>Background: </strong>Comorbidities are major contributors to morbidity and mortality in patients with inflammatory rheumatic diseases (IRDs). We assessed real-world implementation of European Alliance of Associations for Rheumatology (EULAR) points to consider for comorbidity management and perceptions of responsibility.</p><p><strong>Methods: </strong>We conducted a cross-sectional anonymous online survey among patients with IRDs and rheumatologists in Germany. Two questionnaires assessed demographics, perceived responsibility for comorbidity management, and implementation of preventive measures across five domains: cardiovascular risk, infections, malignancies, depression, and osteoporosis. Responses were analysed using descriptive statistics and group comparisons (chi-square, Fisher's exact, Mann-Whitney U tests).</p><p><strong>Results: </strong>A total of 2,213 patients with IRDs and 140 rheumatologists participated. Patient-reported implementation of comorbidity management in routine care was low across all domains (mean 28.8%). Rheumatologists reported substantially higher implementation than patients across all domains, including blood pressure monitoring (83.6% vs 33.8%) and vaccination checks (77.9% vs 33.2%). Most rheumatologists (69.3%) reported that no structured comorbidity screening was in place. Reported barriers included lack of time (91.4%), unclear responsibilities (48.6%), staff shortages (40.0%), and lack of reimbursement (35.0%). Rheumatologists favoured shared responsibility with general practitioners (GPs) for documentation (61.4%) and screening (48.6%), whereas treatment was more often assigned to GPs alone (60.7%). Patients more frequently assigned primary responsibility to GPs, particularly for cardiovascular risk management (72.6%) and vaccinations (73.8%).</p><p><strong>Conclusions: </strong>Comorbidity management in IRDs is poorly implemented in routine care, and perceptions of responsibility differ between patients and rheumatologists. Clearer role definitions, stronger guidance from rheumatology organisations, and practical tools are needed to improve implementation.</p>","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"28 1","pages":""},"PeriodicalIF":4.6,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13695290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149261206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Piezo1-centered mechanotransduction in knee osteoarthritis: multicompartment mechano-inflammatory networks and therapeutic opportunities","authors":"Jing Li,Bo Dong,Xueqin Zeng,Fei Gao,Baohui Wang","doi":"10.1186/s13075-026-03927-2","DOIUrl":"https://doi.org/10.1186/s13075-026-03927-2","url":null,"abstract":"Abstract Knee osteoarthritis (KOA) is increasingly recognized as a whole-joint mechano-inflammatory disorder in which abnormal loading, tissue remodeling, and inflammatory sensitization reinforce one another. Piezo1 is a context-dependent mechanotransduction hub that links mechanical cues to Ca 2+ -dependent inflammatory, catabolic, cell-death, and organelle-stress responses. This focused review, supported by a structured search of PubMed, Web of Science, and China National Knowledge Infrastructure from database inception through June 2, 2026, synthesizes evidence across articular cartilage, synovium, subchondral bone, osteophyte formation, and the pain-related microenvironment. Dysregulated Piezo1-associated signaling has been implicated in extracellular matrix degradation, chondrocyte dysfunction, cell-fate imbalance, and organelle stress. Importantly, Piezo1 is not uniformly pathogenic: excessive activation can aggravate injury in mature chondrocytes and other joint cells, whereas Piezo1 activity may support reparative responses in selected progenitor-cell populations. Preclinical studies have investigated whether traditional Chinese medicine-related interventions alter components of the Piezo1-associated mechano-inflammatory network, although direct target engagement and causal validation remain limited. Artemisinin, wogonin, Shengyu Decoction, and Gubi Zhitong Formula have been associated with changes in distinct molecular modules, whereas evidence linking acupuncture and acupotomy to Piezo1 remains limited to heterogeneous preclinical models and does not establish direct or Piezo1-specific therapeutic mechanisms. However, translation remains limited by heterogeneous models, insufficient compartment- and cell-specific validation, incomplete exposure and target-engagement data, and inconsistent procedural standards. Future studies should integrate local and reversible intervention strategies, rigorous quality control, standardized procedural and stimulation parameters, and cell-specific causal validation. Piezo1 may therefore serve as a stratifiable and testable organizing axis for developing more precise KOA interventions.","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"141 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149208669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Claudia Iannone,Ilaria Magi,Maria Rosa Pellico,Cristina Bochicchio,Antonina Minniti,Roberto Caporali,Nicoletta Del Papa
{"title":"Methotrexate in early systemic sclerosis: skin outcomes and drug survival in real-life practice","authors":"Claudia Iannone,Ilaria Magi,Maria Rosa Pellico,Cristina Bochicchio,Antonina Minniti,Roberto Caporali,Nicoletta Del Papa","doi":"10.1186/s13075-026-03910-x","DOIUrl":"https://doi.org/10.1186/s13075-026-03910-x","url":null,"abstract":"","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"40 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149210498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"GLP-1 receptor agonists as novel renoprotective agents in lupus nephritis","authors":"Xinyu Zhao,Chen Liu,Yongchun Li,Junpeng You,Yuhui Gan,Huimiao Hu,Shuangshuang Li,Weijing Yong,Xiaoyang Wang,Xiaoxue Zhang,Yaling Zhai,Genyang Cheng,Xujie Zhou,Hongde Xu,Yuanyuan Qi","doi":"10.1186/s13075-026-03922-7","DOIUrl":"https://doi.org/10.1186/s13075-026-03922-7","url":null,"abstract":"Abstract Background Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus and a major cause of chronic kidney disease (CKD). Despite advances with immunosuppressive therapy, many patients continue to develop progressive renal impairment. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and CKD, have shown renoprotective effects, but their potential in LN remains undefined. Methods We evaluated the renoprotective effects of liraglutide in lupus-prone MRL/lpr mice using functional, histopathological, and molecular analyses integrated with single-nucleus transcriptomics. Mechanistic studies involved ferroptosis inhibition and pharmacological blockade of cAMP signaling. To provide clinical context, we also describe a patient with class III + V LN who initiated semaglutide during immunosuppressant tapering. Results In lupus-prone MRL/lpr mice, liraglutide reduced proteinuria, improved renal function, and ameliorated histopathological injury without altering systemic autoantibody levels. Single-nucleus transcriptomics revealed cell type–specific remodeling, including suppression of inflammatory and metabolic pathways in podocytes, mesangial, and tubular cells, alongside signatures of tubular repair. Liraglutide treatment was associated with reduced immune infiltration, NF-κB and NLRP3 signaling, fibrosis, oxidative stress, and ferroptosis-related changes, as well as enhanced autophagy. Ferroptosis inhibition recapitulated several protective effects of liraglutide, whereas cAMP blockade attenuated its effects on renal function, inflammation, oxidative stress, and ferroptosis-related parameters. In a single clinical observation, proteinuria decreased following semaglutide initiation during ongoing immunosuppressive management; however, no causal inference can be made from this case. Conclusions GLP-1RAs improved renal outcomes in lupus-prone mice in association with anti-inflammatory, antioxidant, and reduced ferroptosis-related changes. Pharmacological experiments further support the involvement of cAMP signaling and ferroptosis in these renoprotective effects.","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"11 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149208670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annik Steimer,Raphael Micheroli,Claudia Lourenço Rodrigues,Jonas Brändli,Anna E. F. Hadsbjerg,Simon Krabbe,Nora Vladimirova,Iris Eshed,Torsten Diekhoff,Robert G. W. Lambert,Susanne J. Pedersen,Manouk de Hooge,Kristýna Bubová,Monika Gregová,Michael J. Nissen,Burkhard Möller,Jakub Závada,Ziga Snoj,Karlo Pintaric,Bjorn Gudbjornsson,Ziga Rotar,Iwona Sudol-Szopinska,Kasper Gosvig,Alexander Bernatschek,Maurice Donzallaz,Jakob M. Møller,Marie Wetterslev,Stephanie Wichuk,Merete Lund Hetland,Lykke M. Ørnbjerg,Mikkel Østergaard,Adrian Ciurea
{"title":"Progression of sacroiliac joint structural lesions in axial spondyloarthritis: a longitudinal comparative study of MRI and radiography among European patients in routine clinical care","authors":"Annik Steimer,Raphael Micheroli,Claudia Lourenço Rodrigues,Jonas Brändli,Anna E. F. Hadsbjerg,Simon Krabbe,Nora Vladimirova,Iris Eshed,Torsten Diekhoff,Robert G. W. Lambert,Susanne J. Pedersen,Manouk de Hooge,Kristýna Bubová,Monika Gregová,Michael J. Nissen,Burkhard Möller,Jakub Závada,Ziga Snoj,Karlo Pintaric,Bjorn Gudbjornsson,Ziga Rotar,Iwona Sudol-Szopinska,Kasper Gosvig,Alexander Bernatschek,Maurice Donzallaz,Jakob M. Møller,Marie Wetterslev,Stephanie Wichuk,Merete Lund Hetland,Lykke M. Ørnbjerg,Mikkel Østergaard,Adrian Ciurea","doi":"10.1186/s13075-026-03921-8","DOIUrl":"https://doi.org/10.1186/s13075-026-03921-8","url":null,"abstract":"Abstract Background To compare the performances of magnetic resonance imaging (MRI) and radiography in detecting changes in structural lesions of the sacroiliac joints (SIJs) in routine care patients with axial spondyloarthritis (axSpA). Methods SIJ MRIs and radiographs of routine care patients with axSpA in four European countries were collected as part of the EuroSpA Imaging Project. Patients were included if both MRIs and radiographs (≤ 6 months apart) were available at two time points (≥ 1 year apart). Images were evaluated centrally and independently by two trained readers (blinded to chronology and other imaging), applying the Spondyloarthritis Research Consortium of Canada SIJ scores (MRI) and the modified New York criteria (mNY, radiography). Intermodality agreement was assessed cross-sectionally and for change. Results One-hundred-and-five patients (65 male, mean (SD) age 38.1 (10.9) years, symptom duration 9.1 (9.7) years), with a follow-up interval of 2.6 (1.4) years) were included. Baseline agreement between radiography and MRI was slight-to-fair for erosion detection (kappa = 0.12 to 0.42), poor to slight for sclerosis (− 0.04 to 0.07), and substantial to almost perfect for ankylosis (0.66–0.86). Agreement for change over time was poor-to-slight (− 0.04 to 0.20). While lesions remained largely stable on radiography (≤ 6 patients showing change in scores, per lesion type), MRI detected change in at least one lesion in ≥ 50% of patients (positive/negative change in scores (“progression”/”regression”): sclerosis 27/30, erosion 51/38, ankylosis 14/5). A composite MRI score of damage correlated well with mNY grades (Spearman rho = 0.65–0.69). Conclusions Compared to radiography, MRI detected more SIJ structural lesion changes over time, reflecting its ability to capture dynamic changes not readily visible on radiography.","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"12 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149210365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patricia Quaranta,Jagadeesh K. Venkatesan,Valentina Calamia,Patricia Fernández-Puente,Selva Riva-Mendoza,Francisco J. Blanco,Magali Cucchiarini,Cristina Ruiz-Romero
{"title":"Proteomic landscape of IGF-I gene transfer in osteoarthritis-derived human bone marrow stromal cells undergoing chondrogenesis","authors":"Patricia Quaranta,Jagadeesh K. Venkatesan,Valentina Calamia,Patricia Fernández-Puente,Selva Riva-Mendoza,Francisco J. Blanco,Magali Cucchiarini,Cristina Ruiz-Romero","doi":"10.1186/s13075-026-03919-2","DOIUrl":"https://doi.org/10.1186/s13075-026-03919-2","url":null,"abstract":"Abstract Background Osteoarthritis (OA) is a progressive joint disease marked by the breakdown of cartilage and impaired repair capacity. Gene therapy applied to human bone marrow-derived adherent stromal cells (BM-MSCs) with recombinant adeno-associated virus (rAAV) vectors represents a promising strategy for cartilage regeneration. However, the molecular mechanisms underlying its effects remain largely unexplored. In this study, we investigated the proteomic changes induced by rAAV-mediated insulin-like growth factor I (IGF-I) gene transfer during the chondrogenic differentiation of BM-MSCs derived from OA patients. Methods BM-MSCs from OA donors were transduced with recombinant rAAV vectors encoding either IGF-I or the lacZ gene (β-galactosidase) as a control and cultured in three-dimensional micromass systems under chondrogenic conditions for 21 days. Histological, immunohistochemical (IHC) and immunofluorescence (IF) analyses were performed to characterize the chondrogenic phenotype of the model and to provide orthogonal validation of selected proteomic findings. Mass spectrometry-based proteomic profiling identified protein detection patterns and quantitative changes associated with IGF-I overexpression. Pathway and protein-protein interaction (PPI) analyses were carried out to explore the functional implications of differentially expressed proteins. Results A total of 4,284 proteins were identified, of which 112 showed notable changes in detection patterns or abundance associated with IGF-I. Functional enrichment analyses showed involvement of pathways related to metabolism, endoplasmic reticulum (ER) homeostasis, apoptosis regulation, cell proliferation, glycosylation, and the endosomal sorting complex required for transport (ESCRT) machinery. Histological and IHC analyses provided supportive evidence of cartilage-related matrix deposition. Orthogonal validation by IHC and IF confirmed the IGF-I-mediated upregulation of β-catenin and exportin-1 (XPO1). Further analyses provided exploratory evidence of increased active β-catenin and predominantly extranuclear distribution of sirtuin-1, a known XPO1 substrate, in IGF-I-transduced micromasses. Conclusion This study provides the first proteomic characterization of rAAV-mediated IGF-I gene therapy in OA-derived BM-MSCs undergoing chondrogenesis. The IGF-I gene transfer was associated with broad proteomic changes involving metabolic and protein processing pathways, and enhanced cartilage-specific matrix deposition, highlighting molecular mechanisms of potential relevance to cartilage repair in OA.","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"42 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149150397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mieke L. M. Bentvelzen,Wei Yang,Yu Zhang,Alida Kindt,Amy C. Harms,Julia Spierings,Amin Herman,Shasti C. Mooij,Lydia G. Schipper,Harald E. Vonkeman,Simone A. Vreugdenhil,TOFA-PREDICT author group,Kavish J. Bhansing,Sandra T. A. van Bijnen,Radjesh J. Bisoendial,Lenny van Bon,Antoaneta C. Comarniceanu,Tim L. T. A. Jansen,Arno W. R. van Kuijk,Marc R. Kok,Emmerik F. A. Leijten,Z. Nazira Jahangier,Astrid M. van Tubergen,Siska Wijngaarden,Sylvana W. Kadir,Simon C. Mastbergen,Thomas Hankemeier,Paco M. J. Welsing
{"title":"Plasma metabolomics reveals candidate biomarkers associated with individual treatment response in psoriatic arthritis","authors":"Mieke L. M. Bentvelzen,Wei Yang,Yu Zhang,Alida Kindt,Amy C. Harms,Julia Spierings,Amin Herman,Shasti C. Mooij,Lydia G. Schipper,Harald E. Vonkeman,Simone A. Vreugdenhil,TOFA-PREDICT author group,Kavish J. Bhansing,Sandra T. A. van Bijnen,Radjesh J. Bisoendial,Lenny van Bon,Antoaneta C. Comarniceanu,Tim L. T. A. Jansen,Arno W. R. van Kuijk,Marc R. Kok,Emmerik F. A. Leijten,Z. Nazira Jahangier,Astrid M. van Tubergen,Siska Wijngaarden,Sylvana W. Kadir,Simon C. Mastbergen,Thomas Hankemeier,Paco M. J. Welsing","doi":"10.1186/s13075-026-03909-4","DOIUrl":"https://doi.org/10.1186/s13075-026-03909-4","url":null,"abstract":"","PeriodicalId":8419,"journal":{"name":"Arthritis Research & Therapy","volume":"89 1","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149150381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}